CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES >
A case of visceral leishmaniasis with Aspergillus niger infection in Shaanxi Province
Received date: 2024-07-31
Revised date: 2024-09-03
Online published: 2025-01-14
A woman aged 55 years was admitted to Department of Hematology, Shaanxi Nuclear Industry 215 Hospital on April 17, 2024 because of abnormal blood cell parameters for more than 9 months. Multiple routine blood tests showed progressive reductions of blood cells, with the lowest white blood cell count of 1.4 × 109/L, hemoglobin levels of 90 g/L, and platelet levels of 90 × 109/L. The patient was given intermittently cell-boosting treatments with Diyushengbai tablets and granulocyte colony stimulating factors, resulting in difficulty in maintaining white blood cell counts. The case had worked outdoors for a long period of time, and complained of mosquito and sandfly bites. Admission physical examinations showed a body temperature of 37 ℃, blood pressure of 73/43 mmHg (1 mmHg = 0.133 kPa), poor mental health, facial appearance of chronic diseases and soybean-sized scabs and scales scattered on the skin. CT shows slightly enlarged liver, enlarged spleen, widened portal vein, and enlarged spleen. Bone marrow aspiration revealed delayed maturation of megakaryocytes, hypochromic anemia of small cells, and detection of Leishmania-Donovan body in macrophages. Bone marrow biopsy showed phagocytosis of phagocytic cells containing parasites or microorganisms. Metagenomics capture (MetaCAP) pathogen detection showed that the sequence number of L. infantis was 371 554, and the sequence number of Aspergillus niger was 86 880. The diagnosis was visceral leishmaniasis with A. niger infection. Following administer sodium antimony gluconate (6 ml/d) in combination with light shielded pump administration of amphotericin B cholesterol sulfate complex (50 mg/d) for treatment for two weeks, the case had improved symptoms and was discharged from hospital. One-month follow-up showed that routine blood tests returned to normal, and no other remarkable abnormalities.
XING Jia , YU Yanli , WANG Jianjun , XU Shijuan . A case of visceral leishmaniasis with Aspergillus niger infection in Shaanxi Province[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024 , 42(6) : 820 -822 . DOI: 10.12140/j.issn.1000-7423.2024.06.022
| [1] | Ma L, Cao L, Qiu L, et al. Prevalence characteristics and space-time clustering of leishmaniasis in Shaanxi province[J]. Chin J Public Health, 2018, 34(7): 1021-1025. (in Chinese) |
| (马琳, 曹磊, 邱琳, 等. 陕西省黑热病流行病学特征及时空聚类分析[J]. 中国公共卫生, 2018, 34(7): 1021-1025.) | |
| [2] | Kaye PM, Cruz I, Picado A, et al. Leishmaniasis immunopathology-impact on design and use of vaccines, diagnostics and drugs[J]. Semin Immunopathol, 2020, 42(3): 247-264. |
| [3] | Taslimi Y, Zahedifard F, Rafati S. Leishmaniasis and various immunotherapeutic approaches[J]. Parasitology, 2018, 145(4): 497-507. |
| [4] | Maia C, Concei??o C, Pereira A, et al. The estimated distribution of autochthonous leishmaniasis by Leishmania infantum in Europe in 2005-2020[J]. PLoS Negl Trop Dis, 2023, 17(7): e0011497. |
| [5] | Oliveira D, Lopes KF, de Avelar DM, et al. Accuracy of serological tests in diagnosing mucosal leishmaniasis[J]. Parasitol Res, 2023, 122(9): 2001-2010. |
| [6] | Wu XB, Liu K, Shao ZJ. Epidemic status and control measures of visceral leishmaniasis worldwide[J]. Chin J Hyg Insectic Equip, 2023, 29(3): 271-276. (in Chinese) |
| (吴旭斌, 刘昆, 邵中军. 全球内脏利什曼病流行现状与防控进展[J]. 中华卫生杀虫药械, 2023, 29(3): 271-276.) | |
| [7] | Liu JX, Wang JY. Applications of molecular techniques in classification and identification of Leishmania[J]. Chin J Parasitol Parasit Dis, 2020, 38(4): 508-512, 517. (in Chinese) |
| (刘建秀, 汪俊云. 分子技术在利什曼原虫分类与鉴定上的应用[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(4): 508-512, 517.) | |
| [8] | Carrillo E, Moreno J. Editorial: biomarkers in leishmaniasis[J]. Front Cell Infect Microbiol, 2019, 9: 388. |
| [9] | Kassa M, Abdellati S, Cnops L, et al. Diagnostic accuracy of direct agglutination test, rK39 ELISA and six rapid diagnostic tests among visceral leishmaniasis patients with and without HIV coinfection in Ethiopia[J]. PLoS Negl Trop Dis, 2020, 14(12): e0008963. |
| [10] | Mohebali M, Keshavarz H, Shirmohammad S, et al. The diagnostic accuracy of direct agglutination test for serodiagnosis of human visceral leishmaniasis: a systematic review with meta-analysis[J]. BMC Infect Dis, 2020, 20(1): 946. |
| [11] | Alsammar HF, Naseeb S, Brancia LB, et al. Targeted metagenomics approach to capture the biodiversity of Saccharomyces genus in wild environments[J]. Environ Microbiol Rep, 2019, 11(2): 206-214. |
| [12] | Nagy-Szakal D, Couto-Rodriguez M, Wells HL, et al. Targeted hybridization capture of SARS-CoV-2 and metagenomics enables genetic variant discovery and nasal microbiome insights[J]. Microbiol Spectr, 2021, 9(2): e0019721. |
| [13] | Bi HX, Liu YB. Interpretation of diagnosis and treatment plan for kala-azar (2023 edition)[J]. Chin J Antibiot, 2024, 49(7): 729-736. (in Chinese) |
| (毕红霞, 刘焱斌. 《黑热病诊疗方案(2023年版)》解读[J]. 中国抗生素杂志, 2024, 49(7): 729-736.) |
/
| 〈 |
|
〉 |